Patents by Inventor Jammieson C. Pires

Jammieson C. Pires has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of neurogenesis by PDE inhibition
    Patent number: 7985756
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a PDE agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: July 26, 2011
    Assignee: BrainCells Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Kai Treuner
  • MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
    Publication number: 20100216734
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use nootropic agents, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: November 19, 2009
    Publication date: August 26, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain, Dana Gitnick, Jammieson C. Pires
  • NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
    Publication number: 20100120842
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: January 22, 2010
    Publication date: May 13, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
  • Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
    Patent number: 7678363
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: March 16, 2010
    Assignee: BrainCells Inc
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead